Logo image of ABIO.PA

Albioma SA (ABIO.PA) Stock Fundamental Analysis

Europe - Euronext Paris - EPA:ABIO - FR0000060402 - Common Stock

47.14 EUR
+0.04 (+0.08%)
Last: 9/13/2022, 7:00:00 PM
Fundamental Rating

2

Overall ABIO gets a fundamental rating of 2 out of 10. We evaluated ABIO against 21 industry peers in the Independent Power and Renewable Electricity Producers industry. ABIO has a bad profitability rating. Also its financial health evaluation is rather negative. While showing a medium growth rate, ABIO is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

0

1. Profitability

1.1 Basic Checks

  • ABIO had positive earnings in the past year.
ABIO.PA Yearly Net Income VS EBIT VS OCF VS FCFABIO.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 0 50M 100M 150M

1.2 Ratios

Industry RankSector Rank
ROA 2.71%
ROE 9.81%
ROIC 5.3%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ABIO.PA Yearly ROA, ROE, ROICABIO.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2 4 6 8 10

1.3 Margins

Industry RankSector Rank
OM 19.98%
PM (TTM) 8.98%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
ABIO.PA Yearly Profit, Operating, Gross MarginsABIO.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 20 40 60

More info and screens

1

2. Health

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so ABIO is still creating some value.
  • The number of shares outstanding for ABIO has been increased compared to 1 year ago.
  • Compared to 1 year ago, ABIO has a worse debt to assets ratio.
ABIO.PA Yearly Shares OutstandingABIO.PA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 10M 20M 30M
ABIO.PA Yearly Total Debt VS Total AssetsABIO.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 500M 1B 1.5B

2.2 Solvency

  • Based on the Altman-Z score of 1.46, we must say that ABIO is in the distress zone and has some risk of bankruptcy.
  • ABIO has a Debt/Equity ratio of 1.68. This is a high value indicating a heavy dependency on external financing.
Industry RankSector Rank
Debt/Equity 1.68
Debt/FCF N/A
Altman-Z 1.46
ROIC/WACC1.11
WACC4.79%
ABIO.PA Yearly LT Debt VS Equity VS FCFABIO.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 0 200M 400M 600M 800M

2.3 Liquidity

  • A Current Ratio of 1.05 indicates that ABIO should not have too much problems paying its short term obligations.
  • A Quick Ratio of 0.75 indicates that ABIO may have some problems paying its short term obligations.
Industry RankSector Rank
Current Ratio 1.05
Quick Ratio 0.75
ABIO.PA Yearly Current Assets VS Current LiabilitesABIO.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 100M 200M 300M

More info and screens

5

3. Growth

3.1 Past

  • The Earnings Per Share has been growing slightly by 4.36% over the past year.
  • ABIO shows quite a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 10.59% yearly.
  • ABIO shows a strong growth in Revenue. In the last year, the Revenue has grown by 21.04%.
  • The Revenue has been growing by 9.28% on average over the past years. This is quite good.
EPS 1Y (TTM)4.36%
EPS 3Y8.34%
EPS 5Y10.59%
EPS Q2Q%-11.09%
Revenue 1Y (TTM)21.04%
Revenue growth 3Y10.21%
Revenue growth 5Y9.28%
Sales Q2Q%22.65%

3.2 Future

  • ABIO is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 7.39% yearly.
  • ABIO is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 6.22% yearly.
EPS Next Y4%
EPS Next 2Y10.38%
EPS Next 3Y7.07%
EPS Next 5Y7.39%
Revenue Next Year8.28%
Revenue Next 2Y6.4%
Revenue Next 3Y6.91%
Revenue Next 5Y6.22%

3.3 Evolution

  • The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
  • The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
ABIO.PA Yearly Revenue VS EstimatesABIO.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 200M 400M 600M
ABIO.PA Yearly EPS VS EstimatesABIO.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0.5 1 1.5 2 2.5

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

  • With a Price/Earnings ratio of 26.94, ABIO can be considered very expensive at the moment.
  • When comparing the Price/Earnings ratio of ABIO to the average of the S&P500 Index (26.94), we can say ABIO is valued inline with the index average.
  • With a Price/Forward Earnings ratio of 21.36, ABIO is valued on the expensive side.
  • ABIO is valuated at similar levels of the S&P average when we compare the Price/Forward Earnings ratio to 23.94, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 26.94
Fwd PE 21.36
ABIO.PA Price Earnings VS Forward Price EarningsABIO.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA 11.89
ABIO.PA Per share dataABIO.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15

4.3 Compensation for Growth

  • The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates ABIO does not grow enough to justify the current Price/Earnings ratio.
PEG (NY)6.74
PEG (5Y)2.54
EPS Next 2Y10.38%
EPS Next 3Y7.07%

More info and screens

3

5. Dividend

5.1 Amount

  • ABIO has a Yearly Dividend Yield of 1.78%. Purely for dividend investing, there may be better candidates out there.
  • Compared to an average S&P500 Dividend Yield of 1.83, ABIO has a dividend comparable with the average S&P500 company.
Industry RankSector Rank
Dividend Yield 1.78%

5.2 History

  • On average, the dividend of ABIO grows each year by 8.92%, which is quite nice.
Dividend Growth(5Y)8.92%
Div Incr YearsN/A
Div Non Decr YearsN/A
ABIO.PA Yearly Dividends per shareABIO.PA Yearly Dividends per shareYearly Dividends per share 2018 2019 2020 2021 2022 0.2 0.4 0.6 0.8

5.3 Sustainability

  • ABIO's earnings are growing slower than its dividend. This means the dividend growth is not sustainable.
DPN/A
EPS Next 2Y10.38%
EPS Next 3Y7.07%
ABIO.PA Yearly Income VS Free CF VS DividendABIO.PA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 0 20M -20M 40M

More info and screens

Albioma SA

EPA:ABIO (9/13/2022, 7:00:00 PM)

47.14

+0.04 (+0.08%)

Chartmill FA Rating
GICS SectorUtilities
GICS IndustryGroupUtilities
GICS IndustryIndependent Power and Renewable Electricity Producers
Earnings (Last)N/A
Earnings (Next)N/A
Inst OwnersN/A
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap1.52B
Revenue(TTM)633.91M
Net Income(TTM)56.94M
Analysts80
Price Target52.53 (11.43%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 1.78%
Yearly Dividend0.84
Dividend Growth(5Y)8.92%
DPN/A
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 26.94
Fwd PE 21.36
P/S 2.4
P/FCF N/A
P/OCF N/A
P/B 2.62
P/tB N/A
EV/EBITDA 11.89
EPS(TTM)1.75
EY3.71%
EPS(NY)2.21
Fwd EY4.68%
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS19.64
BVpS17.99
TBVpSN/A
PEG (NY)6.74
PEG (5Y)2.54
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA 2.71%
ROE 9.81%
ROCE N/A
ROIC 5.3%
ROICexc N/A
ROICexgc 5.8%
OM 19.98%
PM (TTM) 8.98%
GM N/A
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3Y0%
ROICexgc growth 5Y0%
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score6
Asset Turnover0.3
Health
Industry RankSector Rank
Debt/Equity 1.68
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.05
Quick Ratio 0.75
Altman-Z 1.46
F-Score6
WACC4.79%
ROIC/WACC1.11
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)4.36%
EPS 3Y8.34%
EPS 5Y10.59%
EPS Q2Q%-11.09%
EPS Next Y4%
EPS Next 2Y10.38%
EPS Next 3Y7.07%
EPS Next 5Y7.39%
Revenue 1Y (TTM)21.04%
Revenue growth 3Y10.21%
Revenue growth 5Y9.28%
Sales Q2Q%22.65%
Revenue Next Year8.28%
Revenue Next 2Y6.4%
Revenue Next 3Y6.91%
Revenue Next 5Y6.22%
EBIT growth 1YN/A
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1YN/A
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1YN/A
OCF growth 3YN/A
OCF growth 5YN/A

Albioma SA / ABIO.PA FAQ

What is the fundamental rating for ABIO stock?

ChartMill assigns a fundamental rating of 5 / 10 to ABIO.PA.


What is the valuation status for ABIO stock?

ChartMill assigns a valuation rating of 3 / 10 to Albioma SA (ABIO.PA). This can be considered as Overvalued.


Can you provide the profitability details for Albioma SA?

Albioma SA (ABIO.PA) has a profitability rating of 7 / 10.


Can you provide the PE and PB ratios for ABIO stock?

The Price/Earnings (PE) ratio for Albioma SA (ABIO.PA) is 26.94 and the Price/Book (PB) ratio is 2.62.


How financially healthy is Albioma SA?

The financial health rating of Albioma SA (ABIO.PA) is 4 / 10.